Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 1 clinical guideline sources
7 readers on Mendeley
  • Article usage
  • Citations to this article (46)

Advertisement

Free access | 10.1172/JCI109012

Low Density Lipoprotein: A METABOLIC PATHWAY FOR RETURN OF CHOLESTEROL TO THE SPLANCHNIC BED

A. Sniderman, D. Thomas, D. Marpole, and B. Teng

The Cardiovascular Research Unit, Royal Victoria Hospital, Montreal, Quebec H3A 1A1 Canada

Department of Cardiology, Montreal, Quebec H3A 1A1 Canada

Find articles by Sniderman, A. in: PubMed | Google Scholar

The Cardiovascular Research Unit, Royal Victoria Hospital, Montreal, Quebec H3A 1A1 Canada

Department of Cardiology, Montreal, Quebec H3A 1A1 Canada

Find articles by Thomas, D. in: PubMed | Google Scholar

The Cardiovascular Research Unit, Royal Victoria Hospital, Montreal, Quebec H3A 1A1 Canada

Department of Cardiology, Montreal, Quebec H3A 1A1 Canada

Find articles by Marpole, D. in: PubMed | Google Scholar

The Cardiovascular Research Unit, Royal Victoria Hospital, Montreal, Quebec H3A 1A1 Canada

Department of Cardiology, Montreal, Quebec H3A 1A1 Canada

Find articles by Teng, B. in: PubMed | Google Scholar

Published April 1, 1978 - More info

Published in Volume 61, Issue 4 on April 1, 1978
J Clin Invest. 1978;61(4):867–873. https://doi.org/10.1172/JCI109012.
© 1978 The American Society for Clinical Investigation
Published April 1, 1978 - Version history
View PDF
Abstract

The mechanism(s) by which cholesterol returns to the splanchnic bed from peripheral tissues are not well understood. To study this phenomenon in fasting man, lipoproteins were isolated from plasma obtained from hepatic vein and aorta. Cholesterol content of each lipoprotein class was determined and arteriovenous (AV) differences could be calculated for each patient. The results in the first 24 patients indicated splanchnic secretion of very low density lipoprotein cholesterol (mean AV difference − 3 mg/100 ml, P < 0.01), but not significant AV difference for total cholesterol, high density lipoprotein cholesterol, or low density lipoprotein (LDL) B protein. In contrast, for LDL (d 1.006-1.063 g/ml), there was significant uptake of cholesterol across the AV bed +8 mg/100 ml, P < 0.0002). In a further 15 patients, similar samples were obtained and intermediate density lipoprotein isolated at d 1.006-1.019 g/ml and LDL at 1.019-1.063 g/ml. The AV difference previously noted could now be localized to the 1.019-1.063 cholesterol ester moiety (+8 mg/100 ml, P < 0.0005). In the final 14 patients, the LDL cholesterol AV difference was again confirmed and shown to be unrelated to heparin. As well, there was secretion of triglyceride in the hepatic vein LDL. These quantitative data obtained in man raise the possibility that LDL rather than high density lipoprotein transports cholesterol ester to the splanchnic bed.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 867
page 867
icon of scanned page 868
page 868
icon of scanned page 869
page 869
icon of scanned page 870
page 870
icon of scanned page 871
page 871
icon of scanned page 872
page 872
icon of scanned page 873
page 873
Version history
  • Version 1 (April 1, 1978): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article (46)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 clinical guideline sources
7 readers on Mendeley
See more details